美国偶发前列腺癌的特征
基于SEER数据库2004—2015年数据,344,031例新诊断非转移性前列腺癌中5,155例为偶发癌,年发生率从1.9%升至2.5%(p=0.02)。偶发癌患者中71%未接受局部治疗,6年癌症特异性生存率从GS≥8未治疗者的58%到GS6接受手术或放疗者的100%。
要点
- 偶发前列腺癌年发生率从2004年1.9%升至2015年2.5%(p=0.02)。
- 偶发癌患者中64%为GS6、25%为GS7、11%为GS≥8。
- 未接受局部治疗者比例从65%升至81%(p=0.0001)。
核心结论
- 美国偶发前列腺癌少见,多数患者诊断时年龄小于80岁,多数未接受局部治疗且癌症特异性生存率极佳。
研究设计与样本
- 基于SEER数据库(2004—2015年)识别偶发前列腺癌患者,共344,031例新诊断非转移性前列腺癌中5,155例为偶发癌。
- 使用描述性统计、年度百分比变化(EAPC)、Kaplan-Meier估计及Cox回归模型,并以Bootstrapping技术生成6年癌症特异性生存率的95%置信区间。
主要发现
- 偶发前列腺癌年发生率从2004年1.9%升至2015年2.5%(p=0.02)。
- 诊断时PSA 0-4 ng/ml者占48%,4-10 ng/ml者占31%,>10 ng/ml者占21%。
- GS6者占64%,GS7者占25%,GS≥8者占11%。
- 年龄<70岁者占47%,70-79岁者占35%,≥80岁者占18%。
- 未接受局部治疗者占71%,根治性前列腺切除术者占16%,放疗者占14%。
关键数值与推荐
- 未接受局部治疗者比例从65%升至81%(p=0.0001),研究期间为2004—2015年。
- 6年癌症特异性生存率从GS≥8且未接受局部治疗者的58%到GS6且接受根治性前列腺切除术或放疗者的100%。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Data regarding North-American incidental (cT1a/b) prostate cancer (PCa) patients is scarce. To address this, incidental PCa characteristics (age, PSA values at diagnosis, Gleason score [GS]), subsequent treatment and cancer-specific survival (CSS) rates were explored. METHODS: Incidental PCa patients were identified within the Surveillance, Epidemiology, and End Results (SEER) database (2004-2015). Descriptive statistics, annual percentage changes (EAPC), Kaplan-Meier estimates, as well as Cox regression models were used. Bootstrapping technique was used to generate 95% confidence intervals for CSS at 6 years. RESULTS: Of all 344,031 newly diagnosed non metastatic PCa patients, 5155 harbored incidental PCa. Annual rates of incidental PCa increased from 1.9% (2004) to 2.5 % (2015; p = 0.02). PSA values at diagnosis were 0-4 ng/ml in 48% vs. 4-10 ng/ml in 31% vs. > 10 ng/ml in 21%. Of all incidental PCa patients, 64% harbored GS 6 vs. 25% GS 7 vs. 11% GS ≥ 8. Of all incidental PCa patients, 47% were aged < 70, 35% were between 70 and 79 and 18% were ≥ 80 years. Subsequently, 71% underwent no local treatment (NLT) vs. 16% radical prostatectomy (RP) vs. 14% radiotherapy (RT). Proportions of patients with NLT increased from 65 to 81% (p = 0.0001) over the study period (2004-2015). CSS at six years ranged from 58% in GS ≥ 8 patients with NLT to 100% in patients who harbored GS 6 and underwent either RP or RT. CONCLUSION: Incidental PCa in the United States is rare. Most incidental PCa patients are diagnosed in men aged less than 80 years of age. The majority of incidental PCa patients undergo NLT and enjoy excellent CSS.
引用
- Scheipner L, Incesu RB, Morra S, et al. Characteristics of incidental prostate cancer in the United States. Prostate Cancer Prostatic Dis. 2023. PMID: 37872250. doi:10.1038/s41391-023-00742-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。